Chen Yun, Sparks Megan, Bhandari Poonam, Matkovich Scot J, Dorn Gerald W
Department of Internal Medicine, Center for Pharmacogenomics, Washington University School of Medicine , St. Louis, Missouri.
Antioxid Redox Signal. 2014 Nov 10;21(14):1949-59. doi: 10.1089/ars.2013.5432. Epub 2013 Oct 22.
Mitofusin (Mfn)2 redundantly promotes mitochondrial outer membrane tethering and organelle fusion with Mfn1, and uniquely functions as the mitochondrial receptor for Parkin during PTEN-induced putative kinase 1 (PINK1)-Parkin-mediated mitophagy. Selective deletion of Mfn2 with retention of Mfn1 preserves mitochondrial fusion while rendering damaged mitochondria resistant to normal quality control culling mechanisms. Consequently, neuron and cardiomyocyte-specific Mfn2 gene ablation is associated with accumulation of damaged mitochondria and organ dysfunction. Here, we determined how mitochondrial DNA (mtDNA) damage contributes to cardiomyopathy in Mfn2-deficient hearts.
RNA sequencing of Mfn2-deficient hearts revealed increased expression of some nuclear-encoded mitochondrial genes, but mitochondrial-encoded transcripts were not upregulated in parallel and mtDNA content was decreased. Ultra-deep sequencing of mtDNA showed no increase in single nucleotide mutations, but copy number variations representing insertion-deletion (in-del) mutations were induced over time by cardiomyocyte-specific Mfn2 deficiency. Double-strand mtDNA breaks in the form of in-dels were confirmed by polymerase chain reaction, and in the form of linear mitochondrial genomes were identified by southern blot analysis. Linearization of Drosophila cardiomyocyte mtDNA using conditional cardiomyocyte-specific expression of mitochondrial targeted XhoI recapitulated the cardiomyopathy of Mfn2-deficient mouse hearts.
This is the first description of mitochondrial genome linearization as a causative factor in cardiomyopathy.
One of the consequences of interrupting mitochondrial culling by the PINK1-Mfn2-Parkin mechanism is an increase in mtDNA double-stranded breaks, which adversely impact mitochondrial function and DNA replication.
线粒体融合蛋白(Mfn)2与Mfn1共同促进线粒体外膜连接和细胞器融合,并且在磷酸酶及张力蛋白同源物(PTEN)诱导假定激酶1(PINK1)-Parkin介导的线粒体自噬过程中,独特地作为Parkin的线粒体受体发挥作用。选择性缺失Mfn2而保留Mfn1可维持线粒体融合,同时使受损线粒体对正常的质量控制筛选机制产生抗性。因此,神经元和心肌细胞特异性Mfn2基因缺失与受损线粒体的积累及器官功能障碍相关。在此,我们确定了线粒体DNA(mtDNA)损伤如何导致Mfn2基因缺陷心脏的心肌病。
对Mfn2基因缺陷心脏进行RNA测序发现,一些核编码的线粒体基因表达增加,但线粒体编码的转录本并未平行上调,且mtDNA含量降低。对mtDNA进行超深度测序显示,单核苷酸突变没有增加,但随着时间的推移,心肌细胞特异性Mfn2缺陷会诱导代表插入缺失(in-del)突变的拷贝数变异。通过聚合酶链反应证实了以in-del形式存在的双链mtDNA断裂,并通过Southern印迹分析鉴定了以线性线粒体基因组形式存在的双链mtDNA断裂。利用线粒体靶向XhoI的条件性心肌细胞特异性表达使果蝇心肌细胞mtDNA线性化,重现了Mfn2基因缺陷小鼠心脏的心肌病。
这是首次将线粒体基因组线性化描述为心肌病的致病因素。
通过PINK1-Mfn2-Parkin机制中断线粒体筛选的后果之一是mtDNA双链断裂增加,这对线粒体功能和DNA复制产生不利影响。